Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc.（ELOX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ELOX · 截至 2026年6月13日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Eloxx Pharmaceuticals, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月13日
ELOX 季度内部人买卖趋势
ELOX 内幕交易卖出 · ELOX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 13, 2026
活跃内部人
近12个月交易最活跃 · ELOX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ELOX 高管卖出股份 · ELOX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 27, 2026 | Coastlands Capital LP 10 percent owner | Other | 1,250,000 | — | Form 4 |
| Jan 24, 2026 | Rubin Steven D Director | Option | 1,875 | — | Form 4 |
| Feb 28, 2026 | Aggarwal Sumit President and CEO · Director | Option | 260,946 | $39K | Form 4 |
| Jan 24, 2026 | Aggarwal Sumit President and CEO · Director | Option | 15,000 | — | Form 4 |
| Sep 19, 2025 | Aggarwal Sumit President and CEO · Director | Award | 1,000,000 | — | Form 4 |
| Aug 14, 2025 | Aggarwal Sumit President and CEO · Director | Option | 196,880 | $20 | Form 4 |
| Jan 24, 2026 | Walts Alan Edmund Director | Option | 1,875 | — | Form 4 |
| Jan 24, 2025 | Aggarwal Sumit Director | Option | 30,000 | — | Form 4 |
| Jan 24, 2025 | Rubin Steven D Director | Option | 3,750 | — | Form 4 |
| Jan 24, 2025 | Androski Lindsay Director | Option | 3,750 | — | Form 4 |
| Jan 24, 2025 | Walts Alan Edmund Director | Option | 3,750 | — | Form 4 |
| Oct 16, 2024 | Walts Alan Edmund Director | Award | 12,000 | — | Form 4 |
| Oct 16, 2024 | Androski Lindsay Director | Award | 12,000 | — | Form 4 |
| Oct 16, 2024 | Rubin Steven D Director | Award | 12,000 | — | Form 4 |
| Oct 16, 2024 | Aggarwal Sumit PRESIDENT AND CEO · Director | Award | 165,000 | — | Form 4 |
| Dec 1, 2021 | Walts Alan Edmund Director | Option | 37,695 | — | Form 4 |
| Dec 1, 2021 | Aggarwal Sumit PRESIDENT AND CEO · Director | Option | 279,158 | — | Form 4 |
| Dec 1, 2021 | Aggarwal Sumit PRESIDENT AND CEO · Director | Other | 81,933 | $59K | Form 4 |
| Dec 1, 2021 | MODUR VIJAY HEAD OF R&D | Option | 219,326 | — | Form 4 |
| Dec 1, 2021 | MODUR VIJAY HEAD OF R&D | Other | 64,373 | $46K | Form 4 |
| Nov 29, 2021 | Geffken Daniel E. INTERIM CFO | Purchase | 50,000 | $36K | Form 4 |
| Jul 30, 2021 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option | 1,563 | — | Form 4 |
| Jul 30, 2021 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Other | 459 | $606 | Form 4 |
| May 25, 2021 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option | 6,250 | — | Form 4 |
| May 25, 2021 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Other | 1,835 | $3K | Form 4 |
Aggarwal Sumit
President and CEO · Director
日期
Feb 28
股数
260,946
均价
$0.15
总金额
$39K
Aggarwal Sumit
President and CEO · Director
日期
Aug 14
股数
196,880
均价
$0.00
总金额
$20
Belloff Neil S.
COO, GENERAL COUNSEL &CORP SEC
日期
May 25
股数
1,835
均价
$1.39
总金额
$3K
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ELOX 内幕交易
ELOX 内幕交易
Eloxx Pharmaceuticals, Inc.（ELOX）内幕交易数据来源于公司内部人（包括Aggarwal Sumit (President and CEO · Director), Coastlands Capital LP (10 percent owner), Rubin Steven D (Director)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。ELOX内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Eloxx Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ELOX 内幕交易 · 5个问题Eloxx Pharmaceuticals, Inc.（ELOX）的内部人包括高管和董事，如Aggarwal Sumit (President and CEO · Director), Coastlands Capital LP (10 percent owner), Rubin Steven D (Director)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 13, 2026